이 기사의 번역을 준비하고 있습니다. 그동안 영어 원문을 임시로 표시합니다.
비즈니스 · 2012. 8. 22.1 분 읽기
Ranbaxy Laboratories Limited; Withdrawal of Approval of 27 Abbreviated New Drug Applications
로컬 자동 번역 · 원본 출처 언어
요약
The Food and Drug Administration (FDA) is withdrawing approval of 27 abbreviated new drug applications (ANDAs) held by Ranbaxy Laboratories Ltd., c/o Ranbaxy Inc. (Ranbaxy), 600 College Rd. East, Princeton, NJ 08540. The drug products are no longer marketed, and Ranbaxy has requested that the approval of the applications be withdrawn.
원본 출처 언어: Federal Register — Food and Drug Administration원문 발표 열기 →